Are you Dr. Frey?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 48 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3635 Vista Ave
Saint Louis, MO 63110Phone+1 314-977-5500Fax+1 314-771-3816- Is this information wrong?
Summary
- Dr. Sharon Frey, MD is an infectious disease specialist in Saint Louis, Missouri. She is currently licensed to practice medicine in Missouri. She is affiliated with SSM Health Saint Louis University Hospital and is a Professor of Medicine at Saint Louis University.
Education & Training
St Louis University School of MedicineFellowship, Infectious Disease, 1989 - 1990
SUNY Upstate Medical UniversityFellowship, Infectious Disease, 1988 - 1989- SUNY Upstate Medical UniversityResidency, Internal Medicine, 1985 - 1988
Marshall University Joan C. Edwards School of MedicineClass of 1985
Certifications & Licensure
MO State Medical License 1990 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in Monkeys
- Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults Start of enrollment: 2004 Sep 01
- Phase 1 Norwalk Vaccine Study Start of enrollment: 2008 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsA Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults.Justin R Ortiz, David I Bernstein, Daniel F Hoft, Christopher W Woods, Micah T McClain, Sharon E Frey, Rebecca C Brady, Christopher Bryant, Ashley Wegel, Robert W Fren...> ;The Journal of Infectious Diseases. 2023 Aug 11
- 1 citationsSafety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody Responses.Neuzil, K., Anderson, E., Frenck, R., Frey, S., Walter, E., Rupp, R., Rotrosen, E., Rouphael, N., Brady, R., Graham, I., Schmader, K., Porterfield, L., Ortiz, J., Swam...> ;Clinical Infectious Diseases. 2023 Jan 5
- 2 citationsSafety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adults.Patricia L Winokur, Theresa E Hegmann, Wendy A Keitel, David I Bernstein, Sharon E Frey, Chris Bryant> ;Clinical Infectious Diseases. 2023 Jan 5
- Join now to see all
Press Mentions
SLU Is Looking for Clinical Trial Participants to Test Mpox Vaccine in Adolescents, TeensApril 6th, 2023- As Debate Around School Mask Mandates Heats up, Local Health Officials Fear for Their SafetyAugust 4th, 2021
- Johnson & Johnson Coronavirus Vaccine’s Benefits Still Outweigh Risks, CDC Data ShowJuly 22nd, 2021
- Join now to see all
Grant Support
- HIV Vaccine Clinical Trial Unit At Saint Louis UniverNational Institute Of Allergy And Infectious Diseases2007–2008
Hospital Affiliations
SSM Health Saint Louis University HospitalSaint Louis, Missouri
